a team of EPFL students will take part in the SensUs competition at the Eindhoven University of Technology. This year’s challenge is to develop a biosensor that can quickly measure concentrations in patients’ blood plasma of adalimumab. The main active ingredient of one of the best-selling drugs in the world, which can have harmful side effects.
Media properties
- Themes
- Research and Tech Transfer , STI, Microengineering, Biology, Research and Tech Transfer, Students, Materials Science
- Copyright
- EPFL - Alain Herzog
- Licence
- CC0 Licence
- Shooting date
- Aug. 29, 2019
- Album
- A biosensor to help rheumatoid arthritis patients SensUs - EPFSens
Share on
